These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cytokines in rheumatoid arthritis: trials and tribulations. Carteron NL Mol Med Today; 2000 Aug; 6(8):315-23. PubMed ID: 10904249 [TBL] [Abstract][Full Text] [Related]
24. [Experimental therapy of rheumatoid arthritis with antibodies to tumor necrosis factor]. Manger B Z Rheumatol; 1998 Oct; 57(5):298-301. PubMed ID: 9864834 [No Abstract] [Full Text] [Related]
25. The use of biological agents in the treatment of rheumatoid arthritis. Fan PT; Leong KH Ann Acad Med Singap; 2007 Feb; 36(2):128-34. PubMed ID: 17364080 [TBL] [Abstract][Full Text] [Related]
26. The role and therapeutic targeting of IL-6 in rheumatoid arthritis. Narazaki M; Tanaka T; Kishimoto T Expert Rev Clin Immunol; 2017 Jun; 13(6):535-551. PubMed ID: 28494214 [TBL] [Abstract][Full Text] [Related]
28. A clinical perspective of rheumatoid arthritis. Scherer HU; Burmester GR Eur J Immunol; 2009 Aug; 39(8):2044-8. PubMed ID: 19672900 [TBL] [Abstract][Full Text] [Related]
29. Advances in targeted therapies V: Proceedings of the 5th International Symposium. St Martin, French West Indies. 11-14 April 2003. Ann Rheum Dis; 2003 Nov; 62 Suppl 2():ii1-96. PubMed ID: 14532137 [No Abstract] [Full Text] [Related]
31. Treatment of inflammatory immunologic disease 3. Anti-TNF therapy in rheumatoid arthritis. Takeuchi T Intern Med; 2007; 46(16):1311-2. PubMed ID: 17704613 [No Abstract] [Full Text] [Related]
32. Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis. Jani M; Chinoy H; Warren RB; Griffiths CE; Plant D; Fu B; Morgan AW; Wilson AG; Isaacs JD; Hyrich K; Barton A; Arthritis Rheumatol; 2015 May; 67(8):2011-9. PubMed ID: 26109489 [TBL] [Abstract][Full Text] [Related]